Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HepCURE is a Canadian non-profit healthcare organization established in 2019, dedicated to the elimination of Hepatitis C (HCV) through an innovative, community-based model of care. The company focuses on reaching marginalized and priority populations, such as unhoused individuals and people who use drugs, who face significant barriers to traditional healthcare. HepCURE provides a comprehensive suite of services including mobile point-of-care RNA testing, phlebotomy, medication delivery, and 24/7 patient support. By partnering with organizations like Mednow and Liver Care Canada, HepCURE streamlines the patient journey from diagnosis to cure, achieving high rates of treatment adherence and successful clinical outcomes. The organization is a key player in Canada's efforts to meet the World Health Organization's goal of eradicating HCV by 2030.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HepCURE.